You need to be logged in to view this video

The CIA, CRISPR, and Cholesterol: The Latest Developments in Biotech

Released on Thursday, November 10, 2022ETFs
CRISPR technology has had two watershed moments this summer, indicating that it is about change healthcare as we know it. Since then, there have been investments into CRISPR companies from the CIA and developments in the heart disease space. Learn about the upcoming catalysts for publicly traded gene-editing companies. At its core, CRISPR is a pair of biological scissors that cuts and replaces genes in living organisms' cells.

Kevin Kelly
Kelly ETFs, CEO

Trending Now

Filter By Category
Filter By Keywords